Dallara Que 4

What Happened
Dallara Que, CEO of MiniMed Group, Inc. (MMED), received a grant of 297,618 restricted stock units (RSUs) on 2026-07-01. The award is reported at $0.00 per share (typical for RSU grants); the total dollar value is not stated in the filing. This is an equity award (transaction code A), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-07-01; Form 4 filed 2026-07-06 (appears to be filed after the usual two-business-day window).
• Award: 297,618 RSUs granted (reported acquisition at $0.00).
• Vesting: RSUs vest in approximately equal one-third increments on the first, second and third anniversaries of the grant date (Footnote F1).
• Shares to be issued on vesting; the RSUs convert to common stock upon vesting (Footnote F2).
• Filing also notes inclusion of 1,727 shares acquired under MMED’s 2026 Employee Stock Purchase Plan on 2026-06-30 (Footnote F3).
• Shares owned after transaction: not specified in the filing.

Context
RSU grants are a common form of executive compensation and reflect long-term incentive alignment rather than an immediate market bet; they do not represent a cash purchase or an immediate sale. Because the RSUs vest over three years, the CEO will only receive the underlying shares if they remain with the company until each vesting date. The late filing note may be relevant to compliance monitoring but does not change the economic nature of the award.